Cortina Asset Management’s Collegium Pharmaceutical COLL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
$6.7M Buy
509,701
+228,035
+81% +$3.05M 0.41% 91
2019
Q1
$4.26M Sell
281,666
-174,370
-38% -$2.79M 0.27% 149
2018
Q4
$7.83M Buy
456,036
+62,600
+16% +$1.07M 0.48% 77
2018
Q3
$5.8M Buy
393,436
+26,982
+7% +$478K 0.27% 139
2018
Q2
$8.74M Buy
366,454
+105,585
+40% +$2.6M 0.41% 84
2018
Q1
$6.67M Sell
260,869
-35,794
-12% -$853K 0.33% 105
2017
Q4
$5.48M Buy
+296,663
New +$4.25M 0.24% 159

Other funds holding COLL

Cortina Asset Management's COLL Position: Q2 2019 in Review

Cortina Asset Management increased its Collegium Pharmaceutical (COLL) stake by 81% in Q2 2019, buying an estimated $3.05M and bringing the position to 509,701 shares worth $6.7M. The position accounts for 0.41% of the portfolio, ranked #91.

Cortina Asset Management first reported a position in COLL in Q4 2017 and has held it in 7 quarters since. The position peaked at $8.74M in Q2 2018. 128 funds tracked by Wall St. Rank hold COLL as of Q2 2019.

  • Cortina Asset Management held 509,701 shares of Collegium Pharmaceutical worth $6.7M as of Q2 2019.
  • Cortina Asset Management bought 228,035 Collegium Pharmaceutical shares in Q2 2019, an estimated $3.05M.
  • Collegium Pharmaceutical made up 0.41% of Cortina Asset Management's portfolio in Q2 2019, its #91 holding.
  • Cortina Asset Management first reported a position in Collegium Pharmaceutical in Q4 2017 and has held it in 7 quarters since.
  • Cortina Asset Management's Collegium Pharmaceutical position peaked at $8.74M in Q2 2018.
  • 128 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2019.

Based on Cortina Asset Management's 13F filing for Q2 2019, filed 2 Jul 2019.